2006
DOI: 10.1021/ja061574s
|View full text |Cite
|
Sign up to set email alerts
|

Carbonic Anhydrase Inhibitors:  X-ray and Molecular Modeling Study for the Interaction of a Fluorescent Antitumor Sulfonamide with Isozyme II and IX

Abstract: The X-ray crystal structure of the fluorescent antitumor sulfonamide carbonic anhydrase (CA, EC, 4.2.1.1) inhibitor (4-sulfamoylphenylethyl)thioureido fluorescein (1) in complex with the cytosolic isoform hCA II is reported, together with a modeling study of the adduct of 1 with the tumor-associated isoform hCA IX. Its binding to hCA II is similar to that of other benzesulfonamides, with the ionized sulfonamide coordinated to the Zn2+ ion within the enzyme active site, and also participating in a network of hy… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

5
154
0
2

Year Published

2009
2009
2012
2012

Publication Types

Select...
5
3

Relationship

3
5

Authors

Journals

citations
Cited by 198 publications
(161 citation statements)
references
References 50 publications
5
154
0
2
Order By: Relevance
“…The same NH group made a hydrogen bond with the OH of Thr199 (of 2.86 Å). Furthermore, the two endocyclic nitrogen of the 1,3,4-thidiazole ring participates in two hydrogen bonds (of 2.50-2.80 Å) with the OH of Thr200, as reported earlier for a structurally related compounds [50][51][52][53][54][55][56][57][58][59] . One oxygen of the secondary SO 2 moiety of inhibitor 18 made a hydrogen bond (of 2.97 Å) with the NH 2 of Gln92.…”
Section: Anti-glaucoma Sulphonamides − Hybrid Drugs Incorporating Sulsupporting
confidence: 61%
See 2 more Smart Citations
“…The same NH group made a hydrogen bond with the OH of Thr199 (of 2.86 Å). Furthermore, the two endocyclic nitrogen of the 1,3,4-thidiazole ring participates in two hydrogen bonds (of 2.50-2.80 Å) with the OH of Thr200, as reported earlier for a structurally related compounds [50][51][52][53][54][55][56][57][58][59] . One oxygen of the secondary SO 2 moiety of inhibitor 18 made a hydrogen bond (of 2.97 Å) with the NH 2 of Gln92.…”
Section: Anti-glaucoma Sulphonamides − Hybrid Drugs Incorporating Sulsupporting
confidence: 61%
“…As for other hCA II-sulphonamide adducts investigated earlier [50][51][52][53][54][55][56][57][58][59] , the deprotonated sulphonamide moiety of the inhibitor 18 was found coordinated to the Zn(II) ion at a distance of 1.96 Å 49 . The same NH group made a hydrogen bond with the OH of Thr199 (of 2.86 Å).…”
Section: Anti-glaucoma Sulphonamides − Hybrid Drugs Incorporating Sulmentioning
confidence: 64%
See 1 more Smart Citation
“…2), which are used for imaging purposes and for determining the role of CA9 in tumour acidification 28,39 which is a promiscuous, potent inhibitor of most carbonic anhydrase isoforms. Acetazolamide has been an important lead for generating other inhibitors with a better selectivity profile (compounds 4 and 5; FIG.…”
Section: Sulphonamides As Carbonic Anhydrase Inhibitorsmentioning
confidence: 99%
“…These are the α-CAs (present in vertebrates, bacteria, algae and cytoplasm of green plants); the β-CAs (predominantly in bacteria, algae and chloroplasts of monodicotyledons and dicotyledons); the γ-CAs (mainly in archaea and some bacteria); and the δ-CAs and ζ-CAs (present in some marine diatoms) [1][2][3][4][5][6][7] . In mammals, 16 α-CA isozymes or CA-related proteins with different catalytic activity, subcellular localization and tissue distribution are there [8][9][10][11][12][13][14][15][16][17][18][19][20][21][22][23][24][25] . CAs catalyze a simple physiological reaction the conversion of CO 2 to the bicarbonate ion and protons.…”
Section: Introductionmentioning
confidence: 99%